ENTEROSYS specializes in the preclinical evaluation of compounds of interest in the digestive sphere, the enteric nervous system and the communication between the intestine and the peripheral organs. Thanks to innovative state-of-the-art techniques based on the analysis of physiological parameters in real time, our expertise allows us to develop proofs of concept and precisely study the mechanisms of action of molecules of therapeutic interest (i.e. Candidate drugs, food supplements, etc. to prevent risk factors or treat pathologies where the communication of the intestinal axis and other organs is altered, such as neurodegenerative diseases, metabolic diseases in particular but not only.